Suppression of prolactin and growth hormone responses to 2-deoxy-D-glucose-induced glucoprivation by mazindol in humans
- 1 October 1981
- journal article
- research article
- Published by Elsevier in Metabolism
- Vol. 30 (10), 1015-1020
- https://doi.org/10.1016/0026-0495(81)90103-7
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Dopamine Affects Basal and Augmented Pituitary Hormone Secretion*Journal of Clinical Endocrinology & Metabolism, 1978
- New evidence for growth hormone modulation by the α-adrenergic system in manMetabolism, 1977
- BROMOCRIPTINE THERAPY IN ACROMEGALYThe Lancet, 1975
- Effect of Clonidine on Growth Hormone, Prolactin, Luteinizing Hormone, Follicle-Stimulating Hormone, and Thyroid-Stimulating Hormone in the Serum of Normal MenJournal of Clinical Endocrinology & Metabolism, 1975
- Changes in Plasma Growth Hormone Levels in Normal and Acromegalic Subjects Following Administration of 2-Bromo-?-ErgocryptineJournal of Clinical Endocrinology & Metabolism, 1975
- Long-term Treatment of Galactorrhoea and Hypogonadism with BromocriptineBMJ, 1974
- CHLORPROMAZINE STIMULATION AND L-DOPA SUPPRESSION OF PLASMA PROLACTIN IN MAN1Journal of Clinical Endocrinology & Metabolism, 1971
- Effect of Anterior Pituitary Perfusion and Intraventricular Injection of Catecholamines on Prolactin Release1Endocrinology, 1971
- Catecholamine Inhibition of Prolactin Secretion by Isolated Rat Adenohypophyses1Endocrinology, 1970
- Influence of Norepinephrine and Catecholamine-Depleting Agents on the Synthesis and Release of Prolactin and Growth Hormone1Endocrinology, 1969